Number of Shares
18,431.00
Current Holdings Value*
$4.98 Mil
% of Portfolio
0.56%
Total Estimate Gain
$4.74 Mil
% of Total Estimate Gain
235.76%

T. Rowe Price Extended Equity Market Index Fund's Alnylam Pharmaceuticals Inc Holding Summary

As of 2025-03-31, T. Rowe Price Index Trust, Inc. held 18,431.00 shares of Alnylam Pharmaceuticals Inc(ALNY), totaling $4.98 Mil. This investment constitutes 0.56% of their stock portfolio, and T. Rowe Price Index Trust, Inc. now holds 0.01% of the outstanding Alnylam Pharmaceuticals Inc(ALNY) stock.

The initial trade took place in 2019Q3. And since then T. Rowe Price Extended Equity Market Index Fund has made 2 purchases of ALNY, at an average price of $87.58, for a total of 22,937.00 shares. In addition, there have been 4 sales at an average price of $154.79 for 4,506.00 shares. Based on historical transaction data and ALNY's current price of $328.10, T. Rowe Price Extended Equity Market Index Fund's estimated gain on his ALNY holdings is $4.74 Mil, reflecting a 235.76% gain to date.

T. Rowe Price Extended Equity Market Index Fund ALNY ($328.10) Holding Chart

T. Rowe Price Extended Equity Market Index Fund ALNY ($328.10) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1